Redmile Group LLC 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 15,376,197 5.100% | -6,581,729 (-29.97%) | Filing |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 21,957,926 7.300% | -6,641,568 (-23.22%) | Filing |
| 2023-02-14 4:16 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 28,599,494 9.900% | 194,452 (+0.68%) | Filing |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 28,405,042 9.990% | 6,279,553 (+28.38%) | Filing |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 22,125,489 8.500% | -3,357,280 (-13.17%) | Filing |
| 2020-02-14 4:25 pm Purchase | 2019-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 25,482,769 9.900% | 15,552,766 (+156.62%) | Filing |